603676 卫信康
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)17.23716.71415.4699.3556.110
总资产报酬率 ROA (%)13.11312.43411.1966.7174.385
投入资产回报率 ROIC (%)16.67616.19215.1449.2585.908

边际利润分析
销售毛利率 (%)54.70650.81552.60251.58846.328
营业利润率 (%)23.48713.22811.6279.8968.284
息税前利润/营业总收入 (%)26.94915.99012.82111.0609.754
净利润/营业总收入 (%)24.46516.18112.6539.2798.164

收益指标分析
经营活动净收益/利润总额(%)76.19567.52391.57881.92953.177
价值变动净收益/利润总额(%)5.79211.3138.6409.91419.380
营业外收支净额/利润总额(%)13.54918.93810.83210.45614.847

偿债能力分析
流动比率 (X)3.3613.0392.7662.4072.426
速动比率 (X)3.2722.9422.6872.3532.368
资产负债率 (%)23.33824.56826.71028.63827.709
带息债务/全部投入资本 (%)0.2860.3040.2860.325--
股东权益/带息债务 (%)33,831.83531,837.47233,929.86730,373.846100,797.706
股东权益/负债合计 (%)328.491307.033274.389249.183260.900
利息保障倍数 (X)-122.583-48.724-58.8861,291.491370.569

营运能力分析
应收账款周转天数 (天)49.98654.17552.96773.3300.000
存货周转天数 (天)22.29919.61314.99415.9560.000